BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nichols DP, Donaldson SH, Frederick CA, Freedman SD, Gelfond D, Hoffman LR, Kelly A, Narkewicz MR, Pittman JE, Ratjen F, Sagel SD, Rosenfeld M, Schwarzenberg SJ, Singh PK, Solomon GM, Stalvey MS, Kirby S, VanDalfsen JM, Clancy JP, Rowe SM. PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy. J Cyst Fibros 2021;20:205-12. [PMID: 33619012 DOI: 10.1016/j.jcf.2021.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Grubb BR, Livraghi-butrico A. Animal models of cystic fibrosis in the era of highly effective modulator therapies. Current Opinion in Pharmacology 2022;64:102235. [DOI: 10.1016/j.coph.2022.102235] [Reference Citation Analysis]
2 Barr HL, Bihouee T, Zwitserloot AM. A year in review: Real world evidence, functional monitoring and emerging therapeutics in 2021. J Cyst Fibros 2022:S1569-1993(22)00046-7. [PMID: 35272931 DOI: 10.1016/j.jcf.2022.02.014] [Reference Citation Analysis]
3 Girón Moreno RM, García-Clemente M, Diab-Cáceres L, Martínez-Vergara A, Martínez-García MÁ, Gómez-Punter RM. Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review. Antibiotics (Basel) 2021;10:486. [PMID: 33922413 DOI: 10.3390/antibiotics10050486] [Reference Citation Analysis]
4 King JA, Nichols A, Bentley S, Carr SB, Davies JC. An Update on CFTR Modulators as New Therapies for Cystic Fibrosis. Pediatr Drugs. [DOI: 10.1007/s40272-022-00509-y] [Reference Citation Analysis]
5 Kushary S, Ali N, Spencer JB, Dokson J, Hunt WR. Assessment of a novel genetic counselling intervention to inform assisted reproductive technology treatments and other family-building options in adults with cystic fibrosis. Reprod Biomed Soc Online 2021;13:37-45. [PMID: 34195396 DOI: 10.1016/j.rbms.2021.05.001] [Reference Citation Analysis]